You have 9 free searches left this month | for more free features.

Leukemia, Myeloid

Showing 6426 - 6450 of 6,958

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Memphis (drug, procedure, radiation)

Completed
  • Acute Myeloid Leukemia
  • Fludarabine, Cytarabine, Liposomal daunorubicin (DaunoXome)
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 5, 2011

Leukemia Trial in Belgium, France, Portugal (cytarabine, fludarabine phosphate, idarubicin)

Terminated
  • Leukemia
  • Antwerp, Belgium
  • +22 more
Sep 20, 2012

Advanced or Refractory Leukemia, MDS Trial in Baltimore, Houston (JNJ-26481585)

Terminated
  • Advanced or Refractory Leukemia
  • Myelodysplastic Syndromes
  • Baltimore, Maryland
  • +1 more
Sep 13, 2012

Caregiver Support in Quality of Life of Undergoing Donor Bone

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • psychosocial assessment and care
  • Quality of Life Assessments
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Mar 13, 2012

GVHD, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • anti-thymocyte globulin
  • +6 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Mar 14, 2012

Multiple Myeloma, Leukemia, Lymphoma Trial in Houston (drug, procedure, other)

Completed
  • Multiple Myeloma
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
May 23, 2012

Chronic Lymphocytic Leukemia Trial in China (FFP+HDMP+Rituximab)

Unknown status
  • Chronic Lymphocytic Leukemia
  • Hefei, Anhui, China
  • +13 more
Aug 19, 2012

Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial run by the CC (ravuconazole)

Completed
  • Breast Cancer
  • +11 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Mar 7, 2012

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial run by the CC (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • filgrastim
  • +12 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 7, 2012

Leukemia Trial (Dasatinib)

Completed
  • Leukemia
  • (no location specified)
Apr 25, 2011

Chronic Myeloid Leukemia Trial in New York (Reduced Intensity Conditioning, Busulfan and Fludarabine)

Terminated
  • Chronic Myeloid Leukemia
  • Reduced Intensity Conditioning, Busulfan and Fludarabine
  • New York, New York
    Morgan Stanley Children's Hospital of NYP
Apr 12, 2011

Chronic Lymphocytic Leukemia, Leukemia, Tumors Trial in Tianjin (Bendamustine Hydrochloride Injection, Chlorambucil)

Unknown status
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Tianjin, China
    Hematologic hospital of Chinese academy of medical sciences
Aug 3, 2012

Leukemia Trial in Buffalo (cytarabine, irinotecan HCl)

Completed
  • Leukemia
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 7, 2011

Hematologic Malignancies Trial in Australia, Canada, Korea, Republic of (GSK21110183)

Completed
  • Hematologic Malignancies
  • Sydney, New South Wales, Australia
  • +3 more
Apr 3, 2012

Acute Myeloid Leukemia Trial in New York (decitabine)

Completed
  • Acute Myeloid Leukemia
  • New York, New York
    Weill Medical College of Cornell University
Jun 29, 2011

HTLV-I Infection, T Cell Leukemia Trial run by the NCI (daclizumab)

Completed
  • HTLV-I Infection
  • T Cell Leukemia
  • daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 13, 2012

Leukemia Trial in Houston (Procrit (epoetin alfa))

Completed
  • Leukemia
  • Procrit (epoetin alfa)
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 24, 2012

Cancer Trial (Heparin, Minocycline-EDTA)

Withdrawn
  • Cancer
  • (no location specified)
Feb 22, 2012

Acute Lymphoblastic Leukemia Trial in Worldwide (Liposomal cytarabine, Intrathecal triple)

Suspended
  • Acute Lymphoblastic Leukemia
  • Liposomal cytarabine
  • Intrathecal triple
  • Copenhagen, Denmark
  • +4 more
Oct 6, 2012

Leukemia, Lymphoma, Tumor Lysis Syndrome Trial in Houston (Rasburicase)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Jul 31, 2012

Precursor Lymphoid Tumors Trial in Gliwice (Treatment strategy: induction, consolidation, HSCT, maintenance)

Unknown status
  • Precursor Lymphoid Neoplasms
  • Treatment strategy: induction, consolidation, HSCT, maintenance
  • Gliwice, Poland
    Maria Sklodowska-Curie Memorial Cancer Center and Institute of O
Aug 16, 2012

Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Atlanta (biological, drug, procedure)

Terminated
  • Myeloproliferative Disorders
  • +4 more
  • anti-thymocyte globulin
  • +5 more
  • Atlanta, Georgia
    Blood and Marrow Transplant Group of Georgia
Mar 19, 2012

Leukemia, Lymphocytic, Leukemia, Acute Lymphocytic Leukemia Trial in Stanford (MAb 216, Vincristine)

Completed
  • Leukemia, Lymphocytic
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Jun 29, 2012

Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Chicago (drug, other,

Unknown status
  • Leukemia, Myelogenous, Chronic
  • +4 more
  • Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients
  • +3 more
  • Chicago, Illinois
    Children's Memorial Hospital
Mar 29, 2011

Gastrointestinal Cancer Trial (Nilotinib)

Withdrawn
  • Gastrointestinal Cancer
  • (no location specified)
Aug 1, 2012